Purified anti-alpha-Synuclein, Nitrated Antibody anti-Synuclein-alpha, Nitrated - Syn514,BioLegend,838903

Additional reported applications (for the relevant formats) include: immunofluorescent staining3,7.Syn514 also shows some cross reactivity with beta- and gamma-synuclein.

Host

Mouse

Reactivity

Human

Application

IHC-P -Quality testedICC -Reported in the literature, not verified in house

Platform ID

BAB593183395

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-alpha-Synuclein, Nitrated Antibody anti-Synuclein-alpha, Nitrated - Syn514
Cat. No.838903
HostMouse
RRIDAB_2616740 (BioLegend Cat. No. 838903)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationIHC-P -Quality testedICC -Reported in the literature, not verified in house
ClonalityMonoclonal
Clone NumberSyn514
Concentration0.5 mg/ml
Targetalpha-Synuclein
ImmunogenSyn514 was raised using oxidized alpha-synuclein (α-synuclein) and recognizes its native and nitrated/oxidized forms.
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

Synucleins are small soluble proteins expressed primarily in neural tissues and in certain tumors. The family includes 3 known proteins: alpha-, beta-, and gamma-synuclein. All synucleins have in common a highly conserved alpha helical lipid binding motif with similarity to the class-A2 lipid binding domains of the exchangeable apolipoproteins. The alpha- and beta-synuclein proteins are found primarily in brain tissue, where they are seen mainly in the pre-synaptic terminals. Alpha-synuclein is believed to be a major component of Lewy bodies in Parkinson's disease. Mutations in alpha-synuclein are associated with rare familial cases of early onset Parkinson's disease (PD), Alzheimer's disease (AD) and several other neurodegenerative illnesses. Oxidative injury has been implicated in the pathogenesis of neurodegenerative disorders including AD and PD.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.